| Implementing pharmacogenomics at your institution: establishment and overcoming implementation challenges MJ Arwood, S Chumnumwat, LH Cavallari, EA Nutescu, JD Duarte Clinical and translational science 9 (5), 233, 2016 | 96 | 2016 |
| Optimization of voriconazole therapy for the treatment of invasive fungal infections in adults N Mangal, IS Hamadeh, MJ Arwood, LH Cavallari, TS Samant, KP Klinker, ... Clinical Pharmacology & Therapeutics 104 (5), 957-965, 2018 | 58 | 2018 |
| Anticoagulation Endpoints With Clinical Implementation of Warfarin Pharmacogenetic Dosing in a Real‐World Setting: A Proposal for a New Pharmacogenetic Dosing Approach MJ Arwood, J Deng, K Drozda, O Pugach, EA Nutescu, S Schmidt, ... Clinical Pharmacology & Therapeutics 101 (5), 675-683, 2017 | 31 | 2017 |
| Pharmacogenomics of hypertension and heart disease MJ Arwood, LH Cavallari, JD Duarte Current hypertension reports 17 (9), 76, 2015 | 29 | 2015 |
| Impact of TCF7L2 single nucleotide polymorphisms on hydrochlorothiazide-induced diabetes JH Karnes, Y Gong, MA Pacanowski, CW McDonough, MJ Arwood, ... Pharmacogenetics and genomics 23 (12), 697, 2013 | 25 | 2013 |
| Genome Wide Association Study Identifies the HMGCS2 Locus to be Associated With Chlorthalidone Induced Glucose Increase in Hypertensive Patients S Singh, CW McDonough, Y Gong, WA Alghamdi, MJ Arwood, SA Bargal, ... Journal of the American Heart Association 7 (6), e007339, 2018 | 20 | 2018 |
| Endothelial nitric oxide synthase genotype is associated with pulmonary hypertension severity in left heart failure patients JD Duarte, M Kansal, AA Desai, K Riden, MJ Arwood, AA Yacob, ... Pulmonary circulation 8 (2), 2045894018773049, 2018 | 17 | 2018 |
| Alteration in fasting glucose after prolonged treatment with a thiazide diuretic JH Karnes, Y Gong, MJ Arwood, JG Gums, KL Hall, MC Limacher, ... Diabetes research and clinical practice 104 (3), 363-369, 2014 | 14 | 2014 |
| IGNITE network: Response of patients to genomic medicine interventions LA Orlando, C Voils, CR Horowitz, RA Myers, MJ Arwood, EJ Cicali, ... Molecular Genetics & Genomic Medicine 7 (5), e636, 2019 | 7 | 2019 |
| 2235: Equipping health professional students to apply pharmacogenomic data to clinical decision making in real-world scenarios: Comparison of an active engagement Versus … MJ Arwood, CR McDonough, LH Cavallari, AR Elsey, RF Frye, Y Gong, ... Journal of Clinical and Translational Science 1 (S1), 46-46, 2017 | 2 | 2017 |
| Transcriptome Wide Analysis of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction Patients Implicates Mitochondrial and Proliferative Pathways N Vahabi, MJ Arwood, LH Cavallari, RF Machado, JD Duarte Circulation 138 (Suppl_1), A13456-A13456, 2018 | | 2018 |
| A GENOME WIDE ASSOCIATION STUDY IDENTIFIES PHARMACOGENOMIC VARIANTS ASSOCIATED WITH CHLORTHALIDONE INDUCED GLUCOSE CHANGE IN AFRICAN AMERICANS S Singh, W Alghamdi, MJ Arwood, SA Bargal, F de Oliveira, L Dumeny, ... CLINICAL PHARMACOLOGY & THERAPEUTICS 101 (S 1), S9-S9, 2017 | | 2017 |
| CLINICAL IMPLEMENTATION OF WARFARIN PHARMACOGENETICS IN A REAL-WORLD SETTING: A PROPOSAL FOR A NEW PHARMACOGENETIC DOSING APPROACH FOR DIVERSE PATIENT POPULATIONS MJ Arwood, J Deng, K Drozda, EA Nutescu, S Schmidt, JD Duarte, ... CLINICAL PHARMACOLOGY & THERAPEUTICS 101 (S 1), S5-S5, 2017 | | 2017 |
| Beta-blocker Dose Stratifies Both Mortality Risk and Circulating Procollagen Levels In African-Americans With Heart Failure JD Duarte, MJ Arwood, I Liko, I Mansour, M Kansal, T Stamos, ... Circulation 134 (suppl_1), A11877-A11877, 2016 | | 2016 |
| Development of a Universal Pharmacogenetics-guided Warfarin Dosing Nomogram J Deng, M Arwood, J Duarte, L Cavallari, S Schmidt JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 43, S24-S24, 2016 | | 2016 |
